Life Science Partnering
We take a look today at the partnering 360 blog: http://bit.ly/1wtvMa7
We have made RNA-seq clinically applicable by reengineering sample prep and bioinformatics achieving a 10 fold reduction of cost and a 1000 fold reduction of complexity
A compelling workshop called “The oncology watch list: Next gen immunotherapies” will take place January 14 at Biotech Showcase™ 2015 in San Francisco. The workshop will be moderated by Stephen M. Dunn, President and Senior Managing Director of Research at LifeTech Capital, with panel experts speaking on next generation immunotherapies and what to expect in 2015.
What aspect of cancer immunotherapies do you want the experts to discuss?
While the market is well satruated, what are some of they key opportunities that developers can tap in the app market for healthcare?
Today at the partnering360 blog, we look at a company's best way to get their app/medical device through approval from the FDA. http://www.partnering360.com/blog/2014/12/08/partnerships-are-powerful-in-moving-from-apps-to-medical-devices/
One of the hottest topics at the past BIO-Europe event was immuno-oncology. Today, we look at the challenges of developing this therapy and ask you: Do the benefits of developing immuno-therapy outweigh the challenges?
Read the post here: http://www.partnering360.com/blog/?p=419&preview=true